Related references
Note: Only part of the references are listed.Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
Chandni Hindocha et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Towards a better cannabis drug
Raphael Mechoulam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
M. Jerry Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray
C. G. Stott et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Raymond J. M. Niesink et al.
Frontiers in Psychiatry (2013)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Cannabidiol in Humans-The Quest for Therapeutic Targets
Simon Zhornitsky et al.
PHARMACEUTICALS (2012)
Plasma Cannabinoid Pharmacokinetics following Controlled Oral Delta(9)-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
Erin L. Karschner et al.
CLINICAL CHEMISTRY (2011)
Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
E. L. Karschner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Cognition: The Ultimate Brain Function
Trevor W. Robbins
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Mateus Machado Bergamaschi et al.
CURRENT DRUG SAFETY (2011)
Does cannabidiol protect against the negative effects of THC?
Cecile Henquet et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis
Sagnik Bhattacharyya et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Distinct Effects of Delta 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Psychomotor performance in relation to acute oral administration of Δ9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects
Patrik Roser et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor
Ziva D. Cooper et al.
ADDICTION BIOLOGY (2008)
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Stefan J. Borgwardt et al.
BIOLOGICAL PSYCHIATRY (2008)
Potency of Delta(9)-THC and other cannabinoids in cannabis in England in 2005: Implications for psychoactivity and pharmacology
David J. Potter et al.
JOURNAL OF FORENSIC SCIENCES (2008)
Blunted psychotomimetic and amnestic effects of Δ-9-tetrahydrocannabinol in frequent users of cannabis
Deepak Cyril D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Controversies in translational research: drug self-administration
Margaret Haney et al.
PSYCHOPHARMACOLOGY (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Acute effects of Δ9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity
Georg Juckel et al.
SCHIZOPHRENIA RESEARCH (2007)
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo et al.
MEDICAL HYPOTHESES (2006)
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids
AB Ilan et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Effects of cannabidiol (CBD) on regional cerebral blood flow
JAD Crippa et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Marijuana withdrawal in humans: Effects of oral THC or divalproex
M Haney et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Cannabis versus THC: response to Russo and McPartland
MA ElSohly et al.
PSYCHOPHARMACOLOGY (2003)
Cannabidiol: An overview of some pharmacological aspects
R Mechoulam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Effects of acute smoked marijuana on complex cognitive performance
CL Hart et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Share Paper
